Survival analysis in total joint replacement: An alternative method of accounting for the presence of competing risk

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 5, 2010, Pages 701-706

  Fennema, P ^a   Lubsen, J ^a,b  

^a Netherlands Institute for Health Sciences   (Netherlands)

^b Department of Emeritus ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; JOINT PROSTHESIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REOPERATION; RISK ASSESSMENT; SIMULATION; SURVIVAL; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT, HIP; BIAS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; HIP PROSTHESIS; HUMANS; INCIDENCE; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PROSTHESIS DESIGN; PROSTHESIS FAILURE; REOPERATION; SURVIVAL ANALYSIS;

EID: 77951825295     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B5.23470     Document Type: Article

References (40)

1. Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop Scand 2000;71:433-439
2. Malchau H, Herberts P, Eisler T, Garellick G, Söderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg [Am] 2002;84-A(Suppl 2):2-20. (Pubitemid 35168331)
3. Puolakka TJ, Pajamäki KJ, Halonen PJ, et al. The Finnish Arthroplasty Register: report of the hip register. Acta Orthop Scand 2001;72:433-441 (Pubitemid 33043581)
4. Sheng PY, Konttinen L, Lehto M, et al. Revision total knee arthroplasty: 1990 through 2002: a review of the Finnish arthroplasty registry. J Bone Joint Surg [Am] 2006;88-A:1425-1430
5. National Institute of Clinical Excellence. Guidance on the selection of prostheses for primary total hip replacement (Technology appraisal guidance No. 2). London: NICE, 2000.
6. Carr AJ, Morris RW, Murray DW, Pynsent PB. Survival analysis in joint replacement surgery. J Bone Joint Surg [Br] 1993;75-B:178-182 (Pubitemid 23087169)
7. Lettin AW, Ware HS, Morris RW. Survivorship analysis and confidence intervals: an assessment with reference to the Stanmore total knee replacement. J Bone Joint Surg [Br] 1991;73-B:729-731
8. Britton AR, Murray DW, Bulstrode CJ, McPherson K, Denham RA. Pain levels after total hip replacement: their use as endpoints for survival analysis. J Bone Joint Surg [Br] 1997;79-B:93-98 (Pubitemid 27056432)
9. Dorey F, Amstutz HC. The validity of survivorship analysis in total joint arthroplasty. J Bone Joint Surg [Am] 1989;71-A:544-548 (Pubitemid 19143584)
10. Murray DW, Carr AJ, Bulstrode C. Survival analysis of joint replacements. J Bone Joint Surg [Br] 1993;75-B:697-704.
11. Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. Fourth ed. Malden, MA: Wiley-Blackwell, 2001.
12. Dobbs HS. Survivorship of total hip replacements. J Bone Joint Surg [Br] 1980;62-B:168-173
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
14. Alberti C, Métivier F, Landais P, et al. Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol 2003;56:536-545 (Pubitemid 36842911)
15. Grunkemeier GL, Wu Y. Interpretation of nonfatal events after cardiac surgery: actual versus actuarial reporting. J Thorac Cardiovasc Surg 2001;122:216-219 (Pubitemid 35469986)
16. Cox DR. Regression models and life-tables. J R Stat Soc Series B 1972;34:187-220.
17. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-409
18. Tai BC, Machin D, White I, Gebski V; EOI (The European Osteosarcoma Intergroup). Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Stat Med 2001;20:661-684
19. Southern DA, Faris PD, Brant R, et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006;59:1110-1114 (Pubitemid 44374316)
20. Grunkemeier GL, Anderson RP, Starr A. Actuarial and actual analysis of surgical results: empirical validation. Ann Thorac Surg 2001;71:1885-1887 (Pubitemid 32554418)
21. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993;12:737-751 (Pubitemid 23134304)
22. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990;8:548-555 (Pubitemid 20087556)
23. Yan Y, Moore RD, Hoover DR. Competing risk adjustment reduces overestimation of opportunistic infection rates in AIDS. J Clin Epidemiol 2000;53:817-822 (Pubitemid 30609646)
24. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706. (Pubitemid 29126745)
25. Kalbfleisch JD, Prentice RL. Statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
26. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-554
27. Korn EL, Dorey FJ. Applications of crude incidence curves. Stat Med 1992;11:813-829
28. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990;46:813-826 (Pubitemid 20333612)
29. Marubini E, Valsecchi MG. Analysing survival data from clinical trials and observational studies. New York, NY: John Wiley & Sons, 2004.
30. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002;359:1686-1689
31. No authors listed. ODEP criteria for categorising products in relation to NICE's benchmarks - version 4 January 2005. http://www.supplychain.nhs.uk/ portal/page/portal/Communities/Orthopaedics/ODEP/20database (date last accessed 26 January 2010).
32. Lubsen J, Kirwan BA. Combined endpoints: can we use them? Stat Med 2002;21:2959-2970
33. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997;16:901-910
34. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-1235 (Pubitemid 39424779)
35. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154
36. Coviello V, Boggess M. Cumulative incidence estimation in the presence of competing risk. Stata Journal 2004;4:103-112
37. No authors listed. Australian Orthopaedic Association National Joint Replacement Registry. Annual report 2006. http://www.dmac.adelaide.edu.au/ aoanjrr/publications.jsp?section=reports2005 (date last accessed 25 January 2010).
38. Korovessis P, Petsinis G, Repanti M, Repantis T. Metallosis after contemporary metal-on-metal total hip arthroplasty: five to nine-year follow-up. J Bone Joint Surg [Am] 2006;88-A:1183-1191 (Pubitemid 43837110)
39. Pieringer H, Labek G, Auersperg V, Böhler N. Cementless total hip arthroplasty in patients older than 80 years of age. J Bone Joint Surg [Br] 2003;85-B:641-645 (Pubitemid 36927024)
40. Klapach AS, Callaghan JJ, Miller KA, et al. Total hip arthroplasty with cement and without acetabular bone graft for severe hip dysplasia: a concise follow-up, at a minimum of twenty years, of a previous report. J Bone Joint Surg [Am] 2005;87-A:280-285